Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs

Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs

INDIANAPOLIS, Oct. 7, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) tod...
read more